An E3 Ubiquitin Ligase, Really Interesting New Gene (RING) Finger 41, Is a Candidate Gene for Anxiety-Like Behavior and β-Carboline-Induced Seizures

Biological Psychiatry

Volumn 65, Issue 5, 2009, Pages 425-431

  Kim, Sanghyeon ^a,c   Zhang, Shumin ^a   Choi, Kwang H ^c   Reister, Robin ^a   Do, Chi ^a   Baykiz, Ali F ^a   Gershenfeld, Howard K ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Stanley Laboratory of Brain Research   (United States)

Author keywords

Epilepsy; genetics; mapping; mice; stress; ubiquitin proteasome system

Indexed keywords

BETA CARBOLINE; GLUTATHIONE TRANSFERASE; PROTEIN NOGO A; PROTEIN RNF41; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; AUTOPSY; BIPOLAR DISORDER; CHROMOSOME 10; CONGENIC STRAIN; CONTROLLED STUDY; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; MAJOR DEPRESSION; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; POSTNATAL DEVELOPMENT; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SEIZURE; UPREGULATION; VALIDATION STUDY;

ANIMALS; ANXIETY; BIOLOGICAL MARKERS; BIPOLAR DISORDER; CARBOLINES; CARRIER PROTEINS; DEPRESSIVE DISORDER, MAJOR; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; HUMANS; MALE; MICE; MICE, INBRED STRAINS; PREFRONTAL CORTEX; RNA, MESSENGER; SEIZURES; UBIQUITIN-PROTEIN LIGASES;

EID: 59249098662     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2008.09.015     Document Type: Article

References (48)

1. Bertram L., McQueen M.B., Mullin K., Blacker D., and Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database. Nat Genet 39 (2007) 17-23
2. Ioannidis J.P., Trikalinos T.A., and Khoury M.J. Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am J Epidemiol 164 (2006) 609-614
3. Wellcome-Trust-Case-Control-Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
4. Shifman S., Bhomra A., Smiley S., Wray N.R., James M.R., Martin N.G., et al. A whole genome association study of neuroticism using DNA pooling. Mol Psychiatry 13 (2008) 302-312
5. Flint J., Valdar W., Shifman S., and Mott R. Strategies for mapping and cloning quantitative trait genes in rodents. Nat Rev Genet 6 (2005) 271-286
6. Flint J. Analysis of quantitative trait loci that influence animal behavior. J Neurobiol 54 (2003) 46-77
7. Valdar W., Solberg L.C., Gauguier D., Burnett S., Klenerman P., Cookson W.O., et al. Genome-wide genetic association of complex traits in heterogeneous stock mice. Nat Genet 38 (2006) 879-887
8. Yalcin B., Willis-Owen S.A., Fullerton J., Meesaq A., Deacon R.M., Rawlins J.N., et al. Genetic dissection of a behavioral quantitative trait locus shows that Rgs2 modulates anxiety in mice. Nat Genet 36 (2004) 1197-1202
9. Shirley R.L., Walter N.A., Reilly M.T., Fehr C., and Buck K.J. Mpdz is a quantitative trait gene for drug withdrawal seizures. Nat Neurosci 7 (2004) 699-700
10. Mathis C., Paul S.M., and Crawley J.N. Characterization of benzodiazepine-sensitive behaviors in the A/J and C57BL/6J inbred strains of mice. Behav Genet 24 (1994) 171-180
11. Prut L., and Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: A review. Eur J Pharmacol 463 (2003) 3-33
12. Zhang S., Lou Y., Amstein T.M., Anyango M., Mohibullah N., Osoti A., et al. Fine mapping of a major locus on chromosome 10 for exploratory and fear-like behavior in mice. Mamm Genome 16 (2005) 306-318
13. Le-Niculescu H., McFarland M.J., Mamidipalli S., Ogden C.A., Kuczenski R., Kurian S.M., et al. Convergent Functional Genomics of bipolar disorder: From animal model pharmacogenomics to human genetics and biomarkers. Neurosci Biobehav Rev 31 (2007) 897-903
14. Gershenfeld H.K., Neumann P.E., Mathis C., Crawley J.N., Li X., and Paul S.M. Mapping quantitative trait loci for open-field behavior in mice. Behav Genet 27 (1997) 201-210
15. Gershenfeld H.K., Neumann P.E., Li X., St Jean P.L., and Paul S.M. Mapping quantitative trait loci for seizure response to a GABAA receptor inverse agonist in mice. J Neurosci 19 (1999) 3731-3738
16. Crawley J.N. Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol Biochem Behav 15 (1981) 695-699
17. Kim S., Choi K.H., Baykiz A.F., and Gershenfeld H.K. Suicide candidate genes associated with bipolar disorder and schizophrenia: An exploratory gene expression profiling analysis of post-mortem prefrontal cortex. BMC Genomics 8 (2007) 413
18. Zhang S., Amstein T., Shen J., Brush F.R., and Gershenfeld H.K. Molecular correlates of emotional learning using genetically selected rat lines. Genes Brain Behav 4 (2005) 99-109
19. Formstecher E., Aresta S., Collura V., Hamburger A., Meil A., Trehin A., et al. Protein interaction mapping: A Drosophila case study. Genome Res 15 (2005) 376-384
20. Rain J.C., Selig L., De Reuse H., Battaglia V., Reverdy C., Simon S., et al. The protein-protein interaction map of Helicobacter pylori. Nature 409 (2001) 211-215
21. Wojcik J., Boneca I.G., and Legrain P. Prediction, assessment and validation of protein interaction maps in bacteria. J Mol Biol 323 (2002) 763-770
22. Bouyain S., and Leahy D.J. Structure-based mutagenesis of the substrate-recognition domain of Nrdp1/FLRF identifies the binding site for the receptor tyrosine kinase ErbB3. Protein Sci 16 (2007) 654-661
23. Vikis H.G., and Guan K.L. Glutathione-S-transferase-fusion based assays for studying protein-protein interactions. Methods Mol Biol 261 (2004) 175-186
24. Liu X., Peprah D., and Gershenfeld H.K. Tail-suspension induced hyperthermia: A new measure of stress reactivity. J Psychiatr Res 37 (2003) 249-259
25. Singer J.B., Hill A.E., Nadeau J.H., and Lander E.S. Mapping quantitative trait loci for anxiety in chromosome substitution strains of mice. Genetics 169 (2005) 855-862
26. Gray J.A., and McNaughton N. The neuropsychology of anxiety: Reprise. Nebr Symp Motiv 43 (1996) 61-134
27. Liu X., and Gershenfeld H.K. An exploratory factor analysis of the Tail Suspension Test in 12 inbred strains of mice and an F2 intercross. Brain Res Bull 60 (2003) 223-231
28. Williams R.W., Bennett B., Lu L., Gu J., DeFries J.C., Carosone-Link P.J., et al. Genetic structure of the LXS panel of recombinant inbred mouse strains: A powerful resource for complex trait analysis. Mamm Genome 15 (2004) 637-647
29. Downing C., Carosone-Link P., Bennett B., and Johnson T. QTL mapping for low-dose ethanol activation in the LXS recombinant inbred strains. Alcohol Clin Exp Res 30 (2006) 1111-1120
30. Kendler K.S., Neale M.C., Kessler R.C., Heath A.C., and Eaves L.J. Major depression and generalized anxiety disorder. Same genes, (partly) different environments?. Arch Gen Psychiatry 49 (1992) 716-722
31. Reinstein E., and Ciechanover A. Narrative review: Protein degradation and human diseases: The ubiquitin connection. Ann Intern Med 145 (2006) 676-684
32. Nalepa G., Rolfe M., and Harper J.W. Drug discovery in the ubiquitin-proteasome system. Nat Rev Drug Discov 5 (2006) 596-613
33. Yen L., Cao Z., Wu X., Ingalla E.R., Baron C., Young L.J., et al. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth. Cancer Res 66 (2006) 11279-11286
34. Ryan M.M., Lockstone H.E., Huffaker S.J., Wayland M.T., Webster M.J., and Bahn S. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry 11 (2006) 965-978
35. Avvakumov G.V., Walker J.R., Xue S., Finerty Jr. P.J., Mackenzie F., Newman E.M., et al. Amino-terminal dimerization, NRDP1-rhodanese interaction, and inhibited catalytic domain conformation of the ubiquitin-specific protease 8 (USP8). J Biol Chem 281 (2006) 38061-38070
36. Diamonti A.J., Guy P.M., Ivanof C., Wong K., Sweeney C., and Carraway III K.L. An RBCC protein implicated in maintenance of steady-state neuregulin receptor levels. Proc Natl Acad Sci U S A 99 (2002) 2866-2871
37. Qiu X.B., and Goldberg A.L. Nrdp1/FLRF is a ubiquitin ligase promoting ubiquitination and degradation of the epidermal growth factor receptor family member, ErbB3. Proc Natl Acad Sci U S A 99 (2002) 14843-14848
38. Lotz K., Pyrowolakis G., and Jentsch S. BRUCE, a giant E2/E3 ubiquitin ligase and inhibitor of apoptosis protein of the trans-Golgi network, is required for normal placenta development and mouse survival. Mol Cell Biol 24 (2004) 9339-9350
39. Qiu X.B., Markant S.L., Yuan J., and Goldberg A.L. Nrdp1-mediated degradation of the gigantic IAP, BRUCE, is a novel pathway for triggering apoptosis. Embo J 23 (2004) 800-810
40. Zhong L., Tan Y., Zhou A., Yu Q., and Zhou J. RING finger ubiquitin-protein isopeptide ligase Nrdp1/FLRF regulates parkin stability and activity. J Biol Chem 280 (2005) 9425-9430
41. Wu X., Yen L., Irwin L., Sweeney C., and Carraway III K.L. Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8. Mol Cell Biol 24 (2004) 7748-7757
42. Brajenovic M., Joberty G., Kuster B., Bouwmeester T., and Drewes G. Comprehensive proteomic analysis of human Par protein complexes reveals an interconnected protein network. J Biol Chem 279 (2004) 12804-12811
43. Schwab M.E. Nogo and axon regeneration. Curr Opin Neurobiol 14 (2004) 118-124
44. Buchli A.D., Rouiller E., Mueller R., Dietz V., and Schwab M.E. Repair of the injured spinal cord. A joint approach of basic and clinical research. Neurodegener Dis 4 (2007) 51-56
45. Takeuchi T., Watanabe Y., Takano-Shimizu T., and Kondo S. Roles of jumonji and jumonji family genes in chromatin regulation and development. Dev Dyn 235 (2006) 2449-2459
46. Battaglioli E., Andres M.E., Rose D.W., Chenoweth J.G., Rosenfeld M.G., Anderson M.E., et al. REST repression of neuronal genes requires components of the hSWI.SNF complex. J Biol Chem 277 (2002) 41038-41045
47. Chen J., and Archer T.K. Regulating SWI/SNF subunit levels via protein-protein interactions and proteasomal degradation: BAF155 and BAF170 limit expression of BAF57. Mol Cell Biol 25 (2005) 9016-9027
48. Abiola O., Angel J.M., Avner P., Bachmanov A.A., Belknap J.K., Bennett B., et al. The nature and identification of quantitative trait loci: A community's view. Nat Rev Genet 4 (2003) 911-916